Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies

NCT01355822 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

High Risk Pregnancy

Interventions

DRUG: PETN
DRUG: Placebo control

Sponsor

University of Jena